| Literature DB >> 35541335 |
Chong Yan1, Weiyang Liu1, Jing Li1, Yanlian Deng1, Senhua Chen2, Hongju Liu1.
Abstract
Two new spiromeroterpenoids, namely fusariumin A (1) and B (2), along with four known terpenoids, asperterpenoid A (3), agathic acid (4), guignardone N (5), and trametenolic acid (6), were obtained from the endophytic fungus Fusarium sp. YD-2, derived from the twigs of Santalum album. Their structures were elucidated by a combination of spectroscopic analyses. The absolute configuration of 1 was determined by single-crystal X-ray diffraction using Cu Kα radiation, and that of 2 was elucidated on the basis of experimental and calculated electronic circular dichroism spectra. Compound 2 exhibited moderate anti-inflammatory activity in vitro by inhibiting nitric oxide (NO) production in lipopolysaccharide activated RAW264.7 cells with an IC50 value of 50 μM, and compound 3 showed strong anti-inflammatory activity with an IC50 value of 1.6 μM. In the antibacterial assay, compound 1 displayed significant activities against Staphylococcus aureus and Pseudomonas aeruginosa with an MIC value of 6.3 μg mL-1, and compound 3 showed moderate activities against Salmonella enteritidis and Micrococcus luteus with MIC values of 6.3 and 25.2 μg mL-1, respectively. This journal is © The Royal Society of Chemistry.Entities:
Year: 2018 PMID: 35541335 PMCID: PMC9080035 DOI: 10.1039/c8ra02430h
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 3.361
Fig. 1Structures of compounds 1–6.
1H and 13C NMR data of compounds 1 and 2
| No. | 1 | 2 | ||
|---|---|---|---|---|
|
|
|
|
| |
| 1 | 4.23, d (3.9) | 75.3, CH2 |
| 40.9, CH2 |
|
| ||||
| 2 |
| 35.5, CH2 | 2.33, m | 32.2, CH2 |
|
| ||||
| 3 | 170.1, C | 173.3, C | ||
| 4 | 80.3, C | 85.6, C | ||
| 5 | 1.62, dd (11.6, 4.1) | 51.2, CH | 1.83, m | 52.9, CH |
| 6 | 1.65, m | 22.8, CH2 |
| 34.8, CH2 |
|
| ||||
| 7 | 4.85, m | 72.4, CH | 3.91, m | 80.5, CH |
| 8 | 2.51, m | 46.0, CH | 1.92, m | 50.1, CH |
| 9 | 86.3, C | 100.3, C | ||
| 10 | 50.0, C | 45.5, C | ||
| 11 |
| 49.9, CH2 |
| 44.5, CH2 |
|
|
| |||
| 12 | 1.02, d (7.5) | 10.8, CH3 | 0.91, d (7.0) | 13.9, CH3 |
| 13 |
| 65.5, CH | 1.32, s | 23.1,CH3 |
|
| ||||
| 14 | 1.28, s | 30.8, CH3 | 1.30, s | 34.2, CH3 |
| 15 | 1.15, s | 21.6, CH3 | 1.71, s | 27.0, CH3 |
| 16 | 170.4, C | |||
| 17 | 2.08, s | 21.0, CH3 | ||
| 1′ | 128.1, C | 44.9, C | ||
| 2′ | 107.7, C | 186.8, C | ||
| 3′ | 4.81, d (8.6) | 78.7, CH | 106.7, C | |
| 4′ | 2.72, dd (6.3, 8.6) | 41.8, CH | 195.6, C | |
| 5′ | 2.16, m | 39.6, CH | 3.32, d (3.4) | 59.4, CH |
| 6′ | 47.4, C | 2.52, m | 42.8, CH | |
| 7′ | 174.3, C | 1.26, s | 22.4, CH3 | |
| 8′ | 1.74, s | 22.2, CH3 | 1.70, s | 8.6, CH3 |
| 9′ | 1.19, d (7.3) | 12.2, CH3 | 173.3, C | |
| 10′ | 0.9, s | 19.1, CH3 | 1.05, d (6.7) | 14.7, CH3 |
| 11′ | 3.71, s | 52.7, CH3 | ||
1H (400 MHz) and 13C (100 MHz) NMR data in CDCl3.
1H (400 MHz) and 13C (100 MHz) NMR data in MeOH-d4.
Fig. 2Key HMBC (blue arrows) and 1H–1H COSY (green bold lines) correlations of 1 and 2.
Fig. 3Key NOESY (dash arrows) correlations of 1 and 2.
Fig. 4X-ray crystallographic analysis of compound 1.
Fig. 5Experimental and calculated ECD spectra of compound 2 (in MeOH).
Anti-inflammatory activity of compounds 1–6 in the LPS-induced RAW 264.7 macrophages
| Compounds | IC50 (μM) |
|---|---|
| 1 | >100 |
| 2 | 50.3 |
| 3 | 1.6 |
| 4 | >100 |
| 5 | >100 |
| 6 | >100 |
| Indometacin | 37.5 |
Indometacin was used as a positive control.
Antibacterial activity of compounds 1–6
| Compounds | MIC | |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
| 1 | 6.3 | >50 | >50 | >50 | >50 | >50 | 6.3 | >50 |
| 2 | >50 | >50 | >50 | >50 | >50 | >50 | >50 | >50 |
| 3 | >50 | >50 | >50 | >50 | 25.2 | >50 | >50 | 6.3 |
| 4 | >50 | >50 | >50 | 12.5 | 25.4 | >50 | >50 | >50 |
| 5 | >50 | >50 | >50 | >50 | >50 | >50 | >50 | >50 |
| 6 | >50 | >50 | >50 | >50 | >50 | >50 | >50 | >50 |
| Ciprofloxacin | 0.25 | 0.5 | 0.25 | 0.5 | 0.5 | 0.5 | 0.5 | 0.25 |
Ciprofloxacin was used as positive control.
Data was expressed in MIC values.